Title : Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation.

Pub. Date : 2022 Apr 15

PMID : 35454385






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additional eribulin treatment significantly enhanced PARP cleavage and caspase-3 activity in cisplatin-treated TNBC cells. Cisplatin caspase 3 Homo sapiens